newsfilter
← Latest News
PR Newswire·

Kuehn Law Encourages Investors of Nektar Therapeutics to Contact Law Firm

  • Kuehn Law, PLLC is investigating whether Nektar Therapeutics officers & directors breached fiduciary duties.
  • A federal lawsuit alleges the company misrepresented or failed to disclose that REZOLVE-AA trial enrollment violated protocol standards.
  • The firm claims this non-compliance likely negatively impacted trial results & overstated the product's integrity & prospects.
  • Shareholders who purchased NKTR prior to February 26, 2025, are urged to contact attorney Sophia Anne Silayan.
  • Kuehn Law covers all case costs & charges no fees to investor clients.
  • Contact details for the firm include email sophiaanne@kuehn.law, phone (833) 672-0814, & address in Southampton, NY.